Literature DB >> 16242054

The role of radiosurgery in the management of malignant brain tumors.

Volker W Stieber1, Thomas L Ellis.   

Abstract

Stereotactic radiosurgery (SRS) provides the means for creating lesions in deep-seated areas of the brain inaccessible to invasive surgery, using single high doses of focused ionizing radiation, administered using stereotactic guidance. It is a surgical technique designed to produce a specific radiobiological effect within a sharply defined target region in a single treatment session. Its technical application requires a stereotactic coordinate system, highly accurate patient repositioning (usually fixed), and multiple convergent beams of photon radiation. SRS appears to provide no benefit in the upfront treatment of newly diagnosed malignant gliomas but may be used to effectively palliate small well-demarcated volumes of recurrent disease. For selected patients with brain metastases treated with whole-brain radiation therapy (WBRT), the addition of SRS improves median survival. In selected patients with brain metastases, it is also rational to withhold WBRT in favor of radiosurgery alone, with WBRT reserved for salvage without a decrease in median survival time.

Entities:  

Mesh:

Year:  2005        PMID: 16242054     DOI: 10.1007/s11864-005-0028-8

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  37 in total

1.  Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05.

Authors:  E Shaw; C Scott; L Souhami; R Dinapoli; R Kline; J Loeffler; N Farnan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2000-05-01       Impact factor: 7.038

2.  Stereotactic radiosurgery.

Authors:  L Leksell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

3.  Patterns of failure following high-dose 3-D conformal radiotherapy for high-grade astrocytomas: a quantitative dosimetric study.

Authors:  S W Lee; B A Fraass; L H Marsh; K Herbort; S S Gebarski; M K Martel; E H Radany; A S Lichter; H M Sandler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-01-01       Impact factor: 7.038

4.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System.

Authors:  Jill S Barnholtz-Sloan; Andrew E Sloan; Faith G Davis; Fawn D Vigneau; Ping Lai; Raymond E Sawaya
Journal:  J Clin Oncol       Date:  2004-07-15       Impact factor: 44.544

5.  Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.

Authors:  W J Curran; C B Scott; J Horton; J S Nelson; A S Weinstein; A J Fischbach; C H Chang; M Rotman; S O Asbell; R E Krisch
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

6.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

7.  Multiple brain metastases are associated with poor survival in patients treated with surgery and radiotherapy.

Authors:  M B Hazuka; W D Burleson; D N Stroud; C E Leonard; K O Lillehei; J J Kinzie
Journal:  J Clin Oncol       Date:  1993-02       Impact factor: 44.544

8.  Stereotactic radiosurgery for idiopathic trigeminal neuralgia.

Authors:  Bruce E Pollock; Loi K Phuong; Deborah A Gorman; Robert L Foote; Scott L Stafford
Journal:  J Neurosurg       Date:  2002-08       Impact factor: 5.115

9.  The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.

Authors:  Robert G Selker; William R Shapiro; Peter Burger; Margaret S Blackwood; Vincent C Arena; John C Gilder; Mark G Malkin; John J Mealey; John H Neal; Jeffrey Olson; James T Robertson; Gene H Barnett; Stephen Bloomfield; Robert Albright; Fred H Hochberg; Emile Hiesiger; Sylvan Green
Journal:  Neurosurgery       Date:  2002-08       Impact factor: 4.654

10.  Epidemiology of brain tumors: the national survey of intracranial neoplasms.

Authors:  A E Walker; M Robins; F D Weinfeld
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

View more
  1 in total

1.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.